Table 3.
Prevalence of symptoms clusters/isolated symptoms according to tumor malignancy
| Symptoms | Malignant positive N (%) | Benign positive N (%) | Crude odds ratio (95% CI) | p |
|---|---|---|---|---|
| Cluster abdomen |
41(68.3) |
36 (31.0) |
4.7 (2.4 to 9.3) |
<0.01 |
| Cluster pain |
33 (55.0) |
26 (22.4) |
4.2 (2.1 to 8.2) |
<0.01 |
| Cluster eating |
27 (45.0) |
14 (12.0) |
5.9 (2.8 to 12.6) |
<0.01 |
| Cluster miscellaneous |
21 (35.0) |
18 (15.4) |
2.9 (1.4 to 6.0) |
0.01 |
| Cluster digestion |
18 (30.0) |
10 (8.5) |
4.5 (1.9 to 10.5) |
0.01 |
| Back Pain |
17 (28.3) |
10 (8.6) |
4.1 (1.8 to 9.8) |
<0.01 |
| Able to feel abdominal mass |
14 (23.3) |
11 (9.4) |
2.9 (1.2 to 6.8) |
0.02 |
| Cluster bladder |
14 (23.3) |
20 (17.1) |
1.4 (0.7 to 3.1) |
0.42 |
| Leg swelling | 6 (10.0) | 11 (9.4) | 1.1 (0.4 to 3.0) | 1.0 |
Clusters of symptoms and isolated symptoms were defined by the Ward agglomerative method: abdomen (abdominal bloating and/or increased abdominal size); pain (pelvic and/or abdominal pain); eating (unable to eat normally and/or feeling full quickly); miscellaneous (fatigue and/or difficulty breathing); digestion (indigestion and/or nauseas/vomiting); back pain; able to feel abdominal mass; bladder (urinary urgency and/or frequent urination), leg swelling.